573 related articles for article (PubMed ID: 33302688)
1. A case report of rash induced by cefoperazone sodium and sulbactam sodium plus metronidazole sodium chloride combined with morphine hydrochloride.
Huang J; Zhu X; Jiang C; Liu Z
Ann Palliat Med; 2020 Nov; 9(6):4377-4383. PubMed ID: 33302688
[TBL] [Abstract][Full Text] [Related]
2. Rashes following cesarean delivery: a case report.
Huang J; Zhu X; Jiang C; Liu Z; Zheng W
Ann Palliat Med; 2020 Nov; 9(6):4353-4358. PubMed ID: 33302687
[TBL] [Abstract][Full Text] [Related]
3. Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.
Chandra A; Dhar P; Dharap S; Goel A; Gupta R; Hardikar JV; Kapoor VK; Mathur AK; Modi P; Narwaria M; Ramesh MK; Ramesh H; Sastry RA; Shah S; Virk S; Sudheer OV; Sreevathsa MR; Varshney S; Kochhar P; Somasundaram S; Desai C; Schou M
Surg Infect (Larchmt); 2008 Jun; 9(3):367-76. PubMed ID: 18570578
[TBL] [Abstract][Full Text] [Related]
4. Acute localized exanthematous pustulosis caused by cefoperazone and sodium sulbactam.
Qu YJ; Jin SB; Han XC; Zheng LQ
An Bras Dermatol; 2016; 91(6):808-810. PubMed ID: 28099605
[TBL] [Abstract][Full Text] [Related]
5. Cefoperazone/sulbactam-induced hemolytic anemia.
Sun XM; Liu LH; Wu Q; Wang HG
J Postgrad Med; 2023; 69(1):46-49. PubMed ID: 34528516
[TBL] [Abstract][Full Text] [Related]
6. A fatal case of suspected anaphylaxis with cefoperazone and sulbactam: LC-MS analysis.
Tsujikawa K; Kuwayama K; Miyaguchi H; Kanamori T; Iwata Y; Inoue H; Kishi T
J Forensic Sci; 2008 Jan; 53(1):226-31. PubMed ID: 18279263
[TBL] [Abstract][Full Text] [Related]
7. A case of immune hemolytic anemia induced by ceftizoxime and cefobactam (sulbactam/cefoperazone).
Baek EJ; Lee S; Kim S; Choi HK; Kim HO
Korean J Lab Med; 2009 Dec; 29(6):578-84. PubMed ID: 20046091
[TBL] [Abstract][Full Text] [Related]
8. Pharmacovigilance of cutaneous adverse drug reactions in associations with drugs and medical conditions: a retrospective study of hospitalized patients.
Zheng L; Jin HB; Guan YY; Yang J
BMC Pharmacol Toxicol; 2022 Aug; 23(1):62. PubMed ID: 35948985
[TBL] [Abstract][Full Text] [Related]
9. An open trial of cefoperazone plus sulbactam for the treatment of fever in cancer patients.
Bodey GP; Elting LS; Narro J; Koller C; O'Brien S; Estey E; Benjamin R
J Antimicrob Chemother; 1993 Jul; 32(1):141-52. PubMed ID: 8226405
[TBL] [Abstract][Full Text] [Related]
10. [Treatment with sulbactam/cefoperazone of severe infections in patients with hematological disorders].
Ohno R; Hotta T; Ogura M; Ohnishi K; Morishita T; Murate T; Okumura M; Tanimoto M; Inoue C; Hamaguchi M
Jpn J Antibiot; 1989 Aug; 42(8):1713-9. PubMed ID: 2810734
[TBL] [Abstract][Full Text] [Related]
11. [Clinical experience with the treatment of severe nosocomial infections by inhibitor-protected 3rd generation cephalosporin cefoperazone/sulbactam].
Beloborodova NV; Kuznetsova ST; Popov DA; Bachinskaia EN; Vostrikov TIu
Antibiot Khimioter; 2005; 50(4):33-40. PubMed ID: 16392338
[TBL] [Abstract][Full Text] [Related]
12. Comparison of antibiotic-associated diarrhea caused by cefoperazone/sulbactam or piperacillin/tazobactam in neurosurgery patients.
Chen Y; Xiang Q; Liu L
J Int Med Res; 2021 May; 49(5):3000605211019661. PubMed ID: 34057835
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness study comparing cefoperazone-sulbactam to a three-drug combination for treating intraabdominal infections in an Indian health-care setting.
Kochhar P; Suvarna V; Duttagupta S; Sarkar S
Value Health; 2008 Mar; 11 Suppl 1():S33-8. PubMed ID: 18387065
[TBL] [Abstract][Full Text] [Related]
14. Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia.
Liu JW; Chen YH; Lee WS; Lin JC; Huang CT; Lin HH; Liu YC; Chuang YC; Tang HJ; Chen YS; Ko WC; Lu MC; Wang FD
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138577
[TBL] [Abstract][Full Text] [Related]
15. Cefoperazone / sulbactam induced hyponatremia.
Mitra S; Basu S
Indian J Med Sci; 2006 Apr; 60(4):158-9. PubMed ID: 16679632
[No Abstract] [Full Text] [Related]
16. Cefoperazone and sulbactam-related eosinophilic peritonitis: a case report and literature review.
Wang Z; Li Z; Luo S; Yang Z; Xing Y; Pu C; Dong J
J Int Med Res; 2021 Jun; 49(6):3000605211025367. PubMed ID: 34162261
[TBL] [Abstract][Full Text] [Related]
17. Effect of Cefoperazone/Sulbactam on Blood Coagulation Function in Infected Emergency Department Patients and the Necessity of Vitamin K1 (VK1) Preventive Intervention: A Single-Center, Retrospective Analysis.
Shao X; Ren Y; Xie N; Fan K; Sun H; Lu J; Wei J; Tian X
Med Sci Monit; 2023 Jun; 29():e939203. PubMed ID: 37271979
[TBL] [Abstract][Full Text] [Related]
18. Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study.
Wang W; Liu Y; Yu C; Tan J; Xiong W; Dong D; Li S; Zhang R; Li J; Wu Y; Zong Z; Su N; Zou K; Wu G; Sun X
Expert Opin Drug Saf; 2020 Mar; 19(3):339-347. PubMed ID: 31914329
[No Abstract] [Full Text] [Related]
19. Clinical Efficacy and Safety of Cefoperazone-Sulbactam in Treatment of Intra-Abdominal Infections: A Systematic Review and Meta-Analysis.
Lan SH; Chao CM; Chang SP; Lu LC; Lai CC
Surg Infect (Larchmt); 2021 Oct; 22(8):763-770. PubMed ID: 33625294
[No Abstract] [Full Text] [Related]
20. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
